Home LiteratureArticle Details
PMID: 15577935 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Molecular constraints to interspecies transmission of viral pathogens.

Nature medicine ·Vol. 10 ·No. 12 Suppl ·2004-12-00 ·Pages S77-81

Webby R, Hoffmann E, Webster R

Abstract

The successful replication of a viral pathogen in a host is a complex process involving many interactions. These interactions develop from the coevolution of pathogen and host and often lead to a species specificity of the virus that can make interspecies transmissions difficult. Nevertheless, viruses do sporadically cross species barriers into other host populations, including humans. In zoonotic infections, many of these interspecies transfer events are dead end, where transmission is confined only to the animal-to-human route but sometimes viruses adapt to enable spread from human to human. A pathogen must overcome many hurdles to replicate successfully in a foreign host. The viral pathogen must enter the host cell, replicate with the assistance of host factors, evade inhibitory host products, exit the first cell and move on to the next, and possibly leave the initial host and transmit to another. Each of these stages may require adaptive changes in the pathogen. Although the factors that influence each stage of the replication and transmission of most agents have not been resolved, the genomics of both hosts and pathogens are now at hand and we have begun to understand some of the molecular changes that enable some viruses to adapt to a new host.

MeSH Terms
Animals Antiviral Agents Genome Humans Models, Biological Species Specificity Vaccines Virus Diseases/genetics,prevention & control,transmission Viruses Zoonoses
Chemicals
Antiviral Agents Vaccines
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Webby Richard
Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Hoffmann Erich
Webster Robert
References (46)
46 references, click to expand
  1. Receptor specificity and receptor-induced conformational changes in mouse hepatitis virus spike glycoprotein.
    Adv Exp Med Biol. 2001;494:173-81 PMID: 11774465
  2. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential.
    J Virol. 1998 Sep;72(9):7367-73 PMID: 9696833
  3. Tracing the origin and history of the HIV-2 epidemic.
    Proc Natl Acad Sci U S A. 2003 May 27;100(11):6588-92 PMID: 12743376
  4. STAT2 acts as a host range determinant for species-specific paramyxovirus interferon antagonism and simian virus 5 replication.
    J Virol. 2002 Jul;76(13):6435-41 PMID: 12050355
  5. Arenaviruses: genomic RNAs, transcription, and replication.
    Curr Top Microbiol Immunol. 2002;262:139-57 PMID: 11987804
  6. Mode of action of interferon.
    Nature. 1958 Oct 18;182(4642):1073-4 PMID: 13590226
  7. Evolution of cell recognition by viruses.
    Science. 2001 May 11;292(5519):1102-5 PMID: 11352064
  8. Restriction factors: a defense against retroviral infection.
    Trends Microbiol. 2003 Jun;11(6):286-91 PMID: 12823946
  9. Genetic control of retrovirus susceptibility in mammalian cells.
    Annu Rev Genet. 2004;38:61-85 PMID: 15568972
  10. Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation.
    J Virol. 2002 Nov;76(22):11476-83 PMID: 12388709
  11. Selective incorporation of influenza virus RNA segments into virions.
    Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):2002-7 PMID: 12574509
  12. Efficient initiation of HCV RNA replication in cell culture.
    Science. 2000 Dec 8;290(5498):1972-4 PMID: 11110665
  13. Altered tissue tropism of human-avian reassortant influenza viruses.
    Virology. 1983 Jul 15;128(1):260-3 PMID: 6880029
  14. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs.
    Mol Cell. 1998 Jun;1(7):991-1000 PMID: 9651582
  15. The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties.
    J Virol. 1999 Feb;73(2):1146-55 PMID: 9882316
  16. Replication of avian influenza viruses in humans.
    Arch Virol. 1991;119(1-2):37-42 PMID: 1863223
  17. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China.
    Science. 2003 Oct 10;302(5643):276-8 PMID: 12958366
  18. Amino acid substitutions and an insertion in the spike glycoprotein extend the host range of the murine coronavirus MHV-A59.
    Virology. 2004 Jul 1;324(2):510-24 PMID: 15207636
  19. Viruses and interferon: a fight for supremacy.
    Nat Rev Immunol. 2002 Sep;2(9):675-87 PMID: 12209136
  20. H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity.
    Virology. 2001 Mar 15;281(2):156-62 PMID: 11277689
  21. AIDS as a zoonosis: scientific and public health implications.
    Science. 2000 Jan 28;287(5453):607-14 PMID: 10649986
  22. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor.
    Virology. 1995 Dec 1;214(1):222-8 PMID: 8525619
  23. Hendra virus V protein inhibits interferon signaling by preventing STAT1 and STAT2 nuclear accumulation.
    J Virol. 2003 Nov;77(21):11842-5 PMID: 14557668
  24. Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery.
    EMBO J. 1999 Apr 15;18(8):2273-83 PMID: 10205180
  25. Recombination resulting in virulence shift in avian influenza outbreak, Chile.
    Emerg Infect Dis. 2004 Apr;10(4):693-9 PMID: 15200862
  26. Human and avian influenza viruses target different cell types in cultures of human airway epithelium.
    Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4620-4 PMID: 15070767
  27. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems.
    Virology. 1998 Dec 20;252(2):324-30 PMID: 9878611
  28. Virulence of avian influenza A viruses for squirrel monkeys.
    Infect Immun. 1982 Sep;37(3):1119-26 PMID: 7129631
  29. Contribution of LCMV towards deciphering biology of quasispecies in vivo.
    Curr Top Microbiol Immunol. 2002;263:197-220 PMID: 11987815
  30. Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein.
    Virology. 2003 May 10;309(2):181-9 PMID: 12758165
  31. Ebola virus inhibits induction of genes by double-stranded RNA in endothelial cells.
    Virology. 1998 Dec 5;252(1):179-88 PMID: 9875327
  32. Replication of avian influenza A viruses in mammals.
    Infect Immun. 1981 Nov;34(2):354-61 PMID: 7309229
  33. Genetic recombination in RNA viruses.
    Curr Top Microbiol Immunol. 1992;176:21-32 PMID: 1600753
  34. Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity.
    Virus Res. 1993 Aug;29(2):155-65 PMID: 8212857
  35. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia.
    Nature. 2004 Jul 8;430(6996):209-13 PMID: 15241415
  36. Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins.
    J Virol. 2003 Jan;77(2):1501-11 PMID: 12502864
  37. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics.
    J Virol. 1989 Nov;63(11):4603-8 PMID: 2795713
  38. New insights into the mechanisms of RNA recombination.
    Virology. 1997 Aug 18;235(1):1-9 PMID: 9300032
  39. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.
    N Engl J Med. 1996 Jan 11;334(2):77-81 PMID: 8531962
  40. Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.
    Lancet. 2004 Apr 3;363(9415):1099-103 PMID: 15064027
  41. On the origin of the human influenza virus subtypes H2N2 and H3N2.
    Virology. 1978 Jun 1;87(1):13-20 PMID: 664248
  42. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.
    Nature. 2004 Oct 7;431(7009):703-7 PMID: 15470432
  43. Wet markets--a continuing source of severe acute respiratory syndrome and influenza?
    Lancet. 2004 Jan 17;363(9404):234-6 PMID: 14738798
  44. Virus interference. I. The interferon.
    Proc R Soc Lond B Biol Sci. 1957 Sep 12;147(927):258-67 PMID: 13465720
  45. Highly infectious SARS-CoV pseudotyped virus reveals the cell tropism and its correlation with receptor expression.
    Biochem Biophys Res Commun. 2004 Sep 3;321(4):994-1000 PMID: 15358126
  46. Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus.
    Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3166-71 PMID: 14963236
Article Info
Journal
Nature medicine
Abbr.
Nat Med
ISSN
1078-8956
Published
2004-12-00
Pages
S77-81
Language
English
Region
United States
NLM ID
9502015
PMCID
PMC7095872
Subset
IM
Grants
NIAID NIH HHS · N01AI95357 · United States
NIAID NIH HHS · AI95357 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com